Micro-pollutant and pharmaceutical removal using membrane technology and post-treatment technique
Closed, European procurement for full‑scale demonstration of membrane technology with post‑treatment (O3 or UV‑H₂O₂) to remove micro‑contaminants and pharmaceuticals from waste‑water.
Works · European procedure
01What is being requested
Closed, European procurement for full‑scale demonstration of membrane technology with post‑treatment (O3 or UV‑H₂O₂) to remove micro‑contaminants and pharmaceuticals from waste‑water.
Short description of the assignment/contractual task: In the eastern Netherlands, there is a high concentration of micro-pollutants and pharmaceutical residues in surface water, as evidenced by the national hotspot analysis by STOWA (2017-43). Micro-pollutants are moderately removed in the current aerobic treatment processes of sewage treatment plants but do pose a demonstrable burden on life in surface water. Additionally, the European Urban Wastewater Treatment Directive is being revised, and laws and regulations are being developed regarding the removal of micro-pollutants, specifically pha
02Exclusion grounds
- No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).
03Value in context
04Likely competitors
05Legal themes that may be relevant here
06Frequently asked questions
What is the objective of the proposed assignment?
Which phases does the procurement procedure consist of?
How many candidates are selected in the selection phase?
What is the relationship with the Nationaal Groeifonds (NGF)?
Automatically compiled from the official tender data and documents.
07Estimated value versus the market
€ 1,4 mln
€ 3,6 mln
€ 9,1 mln
Gegunde waarden in CPV 45 · werken n=3159